Fresh Recalls

FDAClass III · Drug · Recall D-0509-2026 · Recalled May 6, 2026

Lidocaine Wound Gel (Benzalkonium Chloride recall — Water-Jel Technologies, LLC

Agency report date: May 6, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Lidocaine Wound Gel (Benzalkonium Chloride
Company / brand
Water-Jel Technologies
Lot / serial / date codes
Lots: A5014, A5018, A5019
Distribution
Nationwide in the USA
Agency product description and boundaries

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed PH Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Lidocaine Wound Gel (Benzalkonium Chloride recall status

3. Open the official notice or contact

Official recall ID
D-0509-2026
Brand
All Water-Jel Technologies recalls
Classification
Class III
Units affected
31,488 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Huntersville, NC, United States
Firm address
13359 Reese Blvd East, 28078

Identifying details (verbatim from the notice)

Product codes / lots
Lots: A5014, A5018, A5019
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
98737
Recall initiated
April 7, 2026
FDA classified
April 30, 2026
FDA report date
May 6, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 4, 2026 at 11:00 PM UTC.

Report a data error on this page